HaTay Pharmaceutical JSC (DHT.VN) Stock Price

HaTay Pharmaceutical JSC Price

CLOSED
49,400.00
​
Market closed

Over the last 17 years HaTay Pharmaceutical JSC grew revenue by 8.3% annually, reaching 2.09 T VND. Earnings per share have grown at 1.0% per year over the last 17 years. For HaTay Pharmaceutical JSC, the net margin of 3.4% is down versus 4.6% a few years ago. At today's price the dividend yield works out to roughly 2.02%. The payout ratio is around 126% of earnings.

HaTay Pharmaceutical JSC stock price

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

HaTay Pharmaceutical JSC business model & stock analysis

Ha Tay Pharmaceutical JSC generates revenue through the manufacturing, import, and export of pharmaceuticals, cosmetics, and medical equipment. The company sells its products via wholesale and retail channels, targeting healthcare providers, pharmacies, and consumers. It also engages in the production and trading of cosmetic products, supplemental food, and laboratory chemicals, alongside medical equipment and supplies. The firm completed the acquisition of a 50.626% stake in Ha Tay Pharmaceutical and Medical Equipments Joint Stock Company in 2013, expanding its market presence in pharmaceuticals and medical equipment. The company operates in the pharmaceutical sector, serving healthcare institutions, retail pharmacies, and end consumers. Its revenue streams include the sale of drugs, cosmetics, medical equipment, and related supplies. Additional income comes from supermarket operations, real estate leasing, and vocational training services, though these are secondary to its core pharmaceutical business. Ha Tay Pharmaceutical JSC's primary customers are healthcare providers, pharmacies, and consumers purchasing pharmaceuticals, cosmetics, and medical equipment. The firm's product portfolio spans drugs, vaccines, cosmetic products, supplemental food, and laboratory chemicals, with a focus on manufacturing and trading. The acquisition of the 50.626% stake in Ha Tay Pharmaceutical and Medical Equipments Joint Stock Company has strengthened its position in the medical equipment market.

Frequently asked questions about HaTay Pharmaceutical JSC

Converted at the current exchange rate, the HaTay Pharmaceutical JSC share trades at 1.70 EUR (49,400.00 VND).

The revenue cannot currently be calculated for HaTay Pharmaceutical JSC.

The profit cannot currently be calculated for HaTay Pharmaceutical JSC.

The P/E ratio cannot be calculated for HaTay Pharmaceutical JSC at the moment.

The P/S cannot be calculated for HaTay Pharmaceutical JSC currently.

The Eulerpool Quality Score for HaTay Pharmaceutical JSC is 6/10.

The ISIN of HaTay Pharmaceutical JSC is VN000000DHT3. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of HaTay Pharmaceutical JSC is DHT.VN. The ticker symbol is used to trade HaTay Pharmaceutical JSC shares on the stock exchange.

Fair ValueTerminal
42,978.00 VND
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Pharmaceuticals
Number of shares
Employees
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Country
Vietnam
Currency
VND
Initial public offering
Dec 3, 2008
ISIN
VN000000DHT3
Cusip
Y31155107
Market capitalization
4.47 T VNDMega Cap
52-Week Range
PEG
—
P/E ratio
P/Ee
—
P/S
P/Se
—
EV/EBIT
63.44
P/B Ratio
4.35
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
4.79 %
Dividend
Dividend yield
2.02 %
Payout Ratio
126.20 %
Dividend growth Ø5Y
10.53 %
Dividend payments per year
2
Dividend paid since
0 years
Dividend not reduced since
0 years
Dividend increased since
0 years
Dividend withholding tax
0.00 %
Last updated Oct 22, 2026, 10:58 AM

HaTay Pharmaceutical JSC Peer Group

HaTay Pharmaceutical JSC FIGI

DHT:VN · BBG000KCYKX2DHT:VH · BBG000KCZNS1